Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1057 of 6351
-
New drug targets Hard-to-Treat lung cancer in phase 2 trial
Disease control OngoingThis study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that overexpress c-Met (c-Met+) best suited for telisotuzumab vedotin therapy in the second line or third line setting (Stage 1) and then to expand the group(s) to further evaluate effi…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can a daily vitamin and sunshine curb Kids' nearsightedness?
Prevention CancelledThe investigators plan on using riboflavin (a Vitamin that can easily be taken orally each day) and having the children involved in the study play outside (where there is UV light created by the sun) in order to prevent the eye from becoming progressively more near-sighted.
Phase 2 • Sponsor: University of Missouri-Columbia • Aim: Prevention
Last updated Aug 26, 2026 00:00 UTC
-
New drug targets genetic weakness in deadly brain tumor
Disease control OngoingThe goal of this clinical trial is to evaluate the safety and efficacy of PLB1001 Enteric Capsules in the treatment of PTPRZ1-MET fusion gene positive recurrent secondary glioblastoma. The main questions it aims to answer are: 1. To evaluate overall survival (OS) in the treatmen…
Phase 2/3 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
A simple silver liquid may halt cavities in Toddlers—Without drilling
Disease control Stopped earlyThis trial is a Phase III, multisite, randomized, placebo-controlled trial, with two parallel groups. The groups are SDF or placebo and they are applied every 6 months. The primary hypothesis of the trial is that SDF is better than placebo for stopping cavities with dentin expose…
Phase 3 • Sponsor: University of Michigan • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
6 months of exercise may boost memory in seniors at risk for Alzheimer's
Prevention CompletedThe investigators aim to compare the effects of a 6-month moderate intensity exercise training (ET) intervention to a low intensity flexibility exercise control condition (FC) on brain function, cognition, and physical function in cognitively healthy and physically inactive older…
Sponsor: University of Maryland, College Park • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
New hope for Hard-to-Treat thyroid cancer: drug slows tumor growth in Late-Stage trial
Disease control OngoingThe objective of this study is to evaluate the effect of cabozantinib compared with placebo on progression free survival (PFS) and objective response rate (ORR) in subjects with Radioiodine-Refractory Differentiated Thyroid Cancer (DTC) who have progressed after prior vascular en…
Phase 3 • Sponsor: Exelixis • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug cocktail shows promise in shrinking advanced melanoma before surgery
Disease control CompletedThis trial studies how well vemurafenib, cobimetinib, and atezolizumab work in treating patients with high-risk stage III melanoma. Vemurafenib and cobimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a Sugar-Clamping technique slash Post-Surgery infections?
Disease control CompletedDespite improvements in surgical techniques and perioperative care, the high incidence of postoperative surgical site infections remains a major problem in patients undergoing major abdominal surgery (liver, pancreatic and colorectal surgery). Using the hyperinsulinemic-normogly…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug cocktail aims to tackle tough mesothelioma
Disease control OngoingThis phase I/II trial studies the side effects and how well pembrolizumab with or without anetumab ravtansine works in treating patients with mesothelin-positive pleural mesothelioma. Anetumab ravtansine is a monoclonal antibody, called anetumab, linked to a chemotherapy drug, ca…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Immunotherapy plus radiation shows promise for tough prostate cancer
Disease control OngoingThe purpose of this study is to test the safety, tolerability, and effectiveness of the investigational drug nivolumab (Opdivo™) in combination with high dose radiation. Investigators also want to see if these study drugs help to delay the progression of prostate cancer.
Phase 1/2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Triple-Drug cocktail shows promise for untreated lung cancer
Disease control CompletedThis is an open-label, non-randomized, phase II clinical research study designed to assess the safety and efficacy of nivolumab and ipilimumab in combination with paclitaxel in patients with treatment naïve NSCLC.
Phase 2 • Sponsor: Jeffrey Clarke • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can surgery beat diabetes in teens? new study investigates
Disease control CompletedType 2 diabetes (T2D) in youth is increasing in prevalence in parallel with the obesity epidemic. In the US, almost half of patients with renal failure have DKD, and ≥80% have T2D. Compared to adult-onset T2D, youth with T2D have a more aggressive phenotype with greater insulin r…
Phase 1/2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Radiation may reboot Cancer-Fighting immune drugs in spreading tumors
Disease control OngoingDrugs called checkpoint inhibitors help the immune system fight cancer. When the effectiveness of these drugs wears off, it may be possible to renew their effectiveness by combining it with a special type of radiation therapy called stereotactic body radiation therapy (SBRT). SBR…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
A bedside score that could foretell heart surgery risks
Knowledge-focused CompletedThis study looked at whether a bedside score called the Vasoactive Inotropic Score (VIS) could help doctors predict which adult patients are at higher risk of complications after heart surgery that uses a heart-lung machine (cardiopulmonary bypass). VIS is calculated from the dos…
Sponsor: Sir Ganga Ram Hospital • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
New hope for kids with sickle cell: drug aims to cut painful crises
Disease control CompletedThe purpose of this study was to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants ages 2 to \<18 years with a history of Vaso-Occlusive Crisis (VOC) with or without Hydroxyurea/Hydroxycarbamide (HU/HC), receiving crizanlizumab for 2…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can a simple blood test forecast heart failure years before it strikes?
Knowledge-focused OngoingAIMS Despite evidence-based therapeutic approaches, target blood pressure is obtained by less than half of patients with hypertension. Hypertension is associated with a significant risk for heart failure (HF), in particular HF with preserved left ventricular (LV) ejection fractio…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Lung cancer study matches drug cocktails to tumor markers
Disease control CompletedThis study will investigate the utility of biomarker-based triage for study participants with advanced non-small cell lung cancer (NSCLC) without prior systemic therapy. Study participants within groups defined by a biomarker-based classifier (gene expression profile \[GEP\] and …
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for kids with tough neuroblastoma? trial tests stronger therapies
Disease control Stopped earlyThe main objective is to evaluate the efficacy of two intensified consolidation strategies in very-high risk neuroblastoma (VHR-NBL) patients in terms of event-free survival from randomisation date. This evaluation will follow a hierarchical testing procedure: each experimental t…
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 26, 2026 13:21 UTC
-
Can stem cells restore fertility in early menopause?
Disease control PausedEvaluate the safety of human umbilical cord mesenchymal stem cells (hucMSCs) in POI treatment; Evaluate the effective hucMSCs in POI treatment. Compare different infusion mode, meanwhile compare with hormone replacement therapy (HRT) withdrawal, so that assessing the stem cell th…
Phase 2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Sound waves to the brain: a new hope for Alzheimer's?
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).
Sponsor: InSightec • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC